RxDoctor Payments Data

Taylor Kohn, NP

Gerontology · North Chesterfield, VANPI 1558042044

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,234 of the $3,975 with a category attached, or 81.4%. Boston Scientific accounts for 73.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $1,976 and has fallen 77.9% since, to $436 in 2025. Among gerontology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,975in general payments, 2019–2025

Across 77 payments — averaging $51.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abbott$117
  • Johnson & Johnson$110
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$104
  • Amgen$98
  • Cardiva Medical, Inc.$92
  • plus $545 from 12 others

What the payments were for

  • Travel & lodging$74119%
  • Food & beverage$3,23481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,975 in reported general payments places this provider in the 90th percentile of 130 gerontology providers in Virginia.

See all gerontology providers in Virginia

Medicare billing

Part B allowed, 2024
$40,407
Medicare patients
290
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban208$185,613
XareltoRivaroxaban91$62,774
EntrestoSacubitril/Valsartan16$16,091
Diltiazem 24hr Er (Cd)Diltiazem Hcl73$2,092
Amiodarone Hcl134$1,606
Metoprolol Succinate150$1,394
Flecainide Acetate76$1,030
Metoprolol Tartrate122$663
SotalolSotalol Hcl18$316
ClopidogrelClopidogrel Bisulfate24$236
Carvedilol39$232
Furosemide86$231
Losartan Potassium30$230
Lisinopril17$173
Spironolactone28$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$90$185,613208 claims
Johnson & JohnsonXarelto$110$62,77491 claims
NovartisEntresto$39$16,09116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 130 gerontology providers in Virginia.

Other gerontology in North Chesterfield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →